{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:53:41Z","timestamp":1782795221485,"version":"3.54.5"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11606-025-10029-3","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:25:00Z","timestamp":1762971900000},"page":"1387-1389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhancing Formulary Accessibility: a Step Toward Better Care"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-221X","authenticated-orcid":false,"given":"Victor C.","family":"Agbafe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S.","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"10029_CR1","unstructured":"New England Healthcare Institute. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease. Cambridge, MA: New England Healthcare Institute, August 12, 2009. https:\/\/www.nehius.org\/hubfs\/pa_issue_brief_final.pdf?hsLang=en"},{"key":"10029_CR2","doi-asserted-by":"publisher","unstructured":"Rohatgi, Karthik W et al.\u00a0Medication Adherence and Characteristics of Patients Who Spend Less on Basic Needs to Afford Medications. J Am Board Family Med: JABFM. 2021;34(3):561\u2013570.\u00a0https:\/\/doi.org\/10.3122\/jabfm.2021.03.200361.","DOI":"10.3122\/jabfm.2021.03.200361"},{"key":"10029_CR3","doi-asserted-by":"publisher","unstructured":"Baryakova TH, Pogostin BH, Langer R. et al. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22:387\u2013409.\u00a0https:\/\/doi.org\/10.1038\/s41573-023-00670-0.","DOI":"10.1038\/s41573-023-00670-0"},{"key":"10029_CR4","doi-asserted-by":"publisher","unstructured":"Ershadi S, Choe J, Barbieri JS. Medicaid formularies for acne treatments are difficult to access and reflect inconsistent coverage policies. J Am Acad Dermatol. 2024;90(5):1074-1076. https:\/\/doi.org\/10.1016\/j.jaad.2024.01.033.\u00a0","DOI":"10.1016\/j.jaad.2024.01.033"},{"key":"10029_CR5","doi-asserted-by":"publisher","unstructured":"Fischer MA, Vogeli C, Stedman M, Ferris T, Brookhart MA, Weissman JS. Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med. 2008;168(22):2433-9. https:\/\/doi.org\/10.1001\/archinte.168.22.2433.\u00a0","DOI":"10.1001\/archinte.168.22.2433"},{"key":"10029_CR6","doi-asserted-by":"publisher","unstructured":"Sahni NR, Istvan B, Stafford C, Cutler D. Perceptions of prior authorization burden and solutions. Health Aff Sch. 2024;2(9):qxae096. https:\/\/doi.org\/10.1093\/haschl\/qxae096.\u00a0","DOI":"10.1093\/haschl\/qxae096"},{"key":"10029_CR7","unstructured":"Centers for Medicare & Medicaid Services. CMS hospital price transparency accuracy and completeness request for information. 2024;CMS. https:\/\/www.cms.gov\/hospital-price-transparency. Accessed\u00a0 20\u00a0Apr 2025."},{"key":"10029_CR8","unstructured":"United States, Federal Trade Commission. The powerful middlemen inflating drug costs and squeezing main street pharmacies: Interim Staff Report. Federal Trade Commission, July 2024, www.ftc.gov\/system\/files\/ftc_gov\/pdf\/pharmacy-benefit-managers-staff-report.pdf.\u00a0Accessed\u00a0 20 Apr 2025."},{"key":"10029_CR9","unstructured":"United States Government Accountability Office. \"Prescription Drugs: Selected States\u2019 Regulation of Pharmacy Benefit Managers.\" GAO, 18 Mar. 2024, www.gao.gov\/products\/gao-24-106898. Accessed 20\u00a0Apr 2025."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10029-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-10029-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10029-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:23:37Z","timestamp":1776255817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-10029-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10029"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-10029-3","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"Victor Agbafe has received consulting fees from Third Culture Capital.\u00a0Victor is an advisor to Apoth Health and DocTalk. Victor is a\u00a0former intern to the Chief Medical Officer for Rightmove Health, a musculoskeletal value-based company, incubated out of the Hospital for Special Surgery. John S. Barbieri has received consulting fees from Sanofi Pasteur and Honeydew Care. Dr. Kesselheim reports serving as an expert witness for the Federal Trade Commission in a case relating to pharmaceutical benefit managers, and for a class of state attorneys general and payors against a large group of generic drug manufacturers related to alleged price fixing. No other disclosures were reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}